Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule
The present invention relates to an immunogenic conjugate comprising a carrier molecule coupled to an autoinducer of a Gram negative bacteria The immunogenic conjugate, when combined with a pharmaceutically acceptable carrier, forms a suitable vaccine for mammals to prevent infection by the Gram negative bacteria The immunogenic conjugate is also used to raise and subsequently isolate antibodies or binding portions thereof which are capable of recognizing and binding to the autoinducer. The antibodies or binding portions thereof are utilized in a method of treating infections, a method of inhibiting autoinducer activity, and in diagnostic assays which detect the presence of autoinducers or autoinducer antagonists in fluid or tissue samples.
1. A method of immunizing a mammalian subject against a Gram negative bacterium that produces an autoinducer comprising administering to the subject an amount of an immunogenic conjugate which comprises an immunogenic carrier molecule covalently conjugated to said autoinducer of said Gram negative bacterium, wherein said autoinducer has the formula:
where X is O, S, N—(C 1 -C 6 ) alkyl, NR 2 , N-phenyl; Y is C 1 -C 6 straight or branched alkyl, C 1 -C 6 straight or branched alkenyl, C 1 -C 6 straight or branched alkynyl; Z is C═O, C═S, CHOH, C═N—NR 1 , C═N—OH, C 1 -C 8 straight or branched alkyl, C 1 -C 8 straight or branched alkenyl, C 1 -C 8 straight or branched alkynyl; L is C 1 -C 18 straight or branched alkyl, C 1 -C 18 straight or branched alkenyl, C 1 -C 18 straight branched alkynyl, or —CO 2 H, —CO 2 R 1 , —CHO, —C≡N, —N═C═O, —N═C═S, OH, OR 1 , —CH═CH—CH 2 Br, —CH═CH—CH 2 Cl, —SAc or SH, where R 1 is C 1 -C 6 straight or branched alkyl, m is 0 or 1; z is 0 or 1; R 2 is H, C 1 -C 6 straight or branched alkyl, C 1 -C 6 straight or branched alkenyl or C 1 -C 6 straight or branched alkynyl, or CO 2 H; and Q is CH or N; and n is 0-3 with the proviso that when n is 0, X is N—(C 1 -C 6 alkyl) or N-phenyl, in which said amount is effective to immunize the subject against said Gram negative bacterium.
2. The method of claim 1 wherein said immunogenic conjugate is administered orally, intradermally, intramuscularly, intraperitoneally, intravenously, subcutaneous, or intranasally.
3. The method of claim 1 wherein said subject is a human.
4. The method of claim 1 wherein the Gram negative bacteria is selected from the group consisting of Aeromonas hydrophila, Agrobacterium tumefaciens, Burkholderia cepacia, Chromobacterium violaceum, Enterobacter agglomerans, Erwinia stewarti, Erwinia carotovora, Escherichia coli, Nitrosomas europea, Photobacterium fischeri, Pseudomonas aeruginosa, Pseudomonas aureofaciens, Rhizobium leguminosarum, Serratia liquefaciens , and Vibrio harveyi.